Bicara Therapeutics Inc.
BCAX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002023658
In the last 90 days, Bicara Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 171 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.
Superinvestors holding BCAX, Q2 2026
No superinvestor reported holding BCAX in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of BCAX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2024
0 superinvestors holding at quarter end
- Sold out
- Soros Fund Management
Q3 2024
1 superinvestor holding at quarter end